Novan Investor Relations Material
Latest events
Q1 2023
Novan
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novan Inc
Access all reports
Novan Inc. is a biotechnology company specializing in the development of nitric oxide-based therapies for dermatological and infectious diseases. The company’s proprietary NITRICIL platform enables the controlled release of nitric oxide to target specific medical conditions. Novan’s pipeline includes treatments for skin diseases such as acne, atopic dermatitis, and warts, as well as broader applications in antiviral and antimicrobial therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NOVN
Country
🇺🇸 United States